BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9539251)

  • 1. Model for the molecular genetic diagnosis of endometrial cancer using K-ras mutation analysis.
    Al-Jehani RM; Jeyarajah AR; Hagen B; Hogdall EV; Oram DH; Jacobs IJ
    J Natl Cancer Inst; 1998 Apr; 90(7):540-2. PubMed ID: 9539251
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinicopathological significance of K-RAS point mutation and gene amplification in endometrial cancer.
    Esteller M; García A; Martínez-Palones JM; Xercavins J; Reventós J
    Eur J Cancer; 1997 Sep; 33(10):1572-7. PubMed ID: 9389917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations and amplification of oncogenes in endometrial cancer.
    Niederacher D; An HX; Cho YJ; Hantschmann P; Bender HG; Beckmann MW
    Oncology; 1999; 56(1):59-65. PubMed ID: 9885379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Point mutation of ras oncogene in endometrial carcinoma].
    Fujimoto I; Hasumi K
    Rinsho Byori; 1993 Jun; Suppl 94():29-37. PubMed ID: 8103124
    [No Abstract]   [Full Text] [Related]  

  • 5. ras gene mutations in human endometrial carcinoma.
    Varras MN; Koffa M; Koumantakis E; Ergazaki M; Protopapa E; Michalas S; Spandidos DA
    Oncology; 1996; 53(6):505-10. PubMed ID: 8960147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gene K-ras mutation in cells of endometrial adenocarcinoma in women].
    Semczuk A; Wojcierowski J; Kitlińska J; Kotarski J; Rózańska K
    Ginekol Pol; 1996 May; 67(5):259-63. PubMed ID: 8925998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of the Ki-ras oncogene in carcinoma of the endometrium.
    Caduff RF; Johnston CM; Frank TS
    Am J Pathol; 1995 Jan; 146(1):182-8. PubMed ID: 7856726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of K-ras gene mutations in DNA extracted from the plasma of patients with pancreatic cancer].
    Feng D; Han T; Jiang Y; Yuan Z; Wang X; Jiang Z; Zhang S
    Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):767-70. PubMed ID: 11832160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma.
    Caduff RF; Johnston CM; Svoboda-Newman SM; Poy EL; Merajver SD; Frank TS
    Am J Pathol; 1996 May; 148(5):1671-8. PubMed ID: 8623934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H-ras oncogene mutation in dedifferentiated chondrosarcoma: polymerase chain reaction-restriction fragment length polymorphism analysis.
    Sakamoto A; Oda Y; Adachi T; Oshiro Y; Tamiya S; Tanaka K; Matsuda S; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2001 Apr; 14(4):343-9. PubMed ID: 11301351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved detection of K-ras codon 12 mutations in fecal exfoliated cells.
    Puig P; Urgell E; Capellá G; Villanueva A; Grau M; Sancho FJ; Pujol J; Lluís F; González-Sastre F; Mora J
    Lab Invest; 1999 May; 79(5):617-8. PubMed ID: 10334573
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of K-ras mutations in the plasma DNA of pancreatic cancer patients.
    Uemura T; Hibi K; Kaneko T; Takeda S; Inoue S; Okochi O; Nagasaka T; Nakao A
    J Gastroenterol; 2004 Jan; 39(1):56-60. PubMed ID: 14767735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic detection of mutant ras genes in minor cell populations.
    Kahn SM; Jiang W; Weinstein IB; Perucho M
    Methods Enzymol; 1995; 255():452-64. PubMed ID: 8524131
    [No Abstract]   [Full Text] [Related]  

  • 14. H-ras oncogene mutation in dedifferentiated liposarcoma. Polymerase chain reaction-restriction fragment length polymorphism analysis.
    Sakamoto A; Oda Y; Adachi T; Tamiya S; Matsuda S; Tanaka K; Iwamoto Y; Tsuneyoshi M
    Am J Clin Pathol; 2001 Feb; 115(2):235-42. PubMed ID: 11211612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic alterations in SMAD4 and K-ras in Serbian patients with endometrial carcinoma.
    Nikolic A; Ristanovic M; Perovic V; Trifunovic J; Perovic M; Radojkovic D
    Int J Gynecol Cancer; 2012 Mar; 22(3):442-6. PubMed ID: 22266936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma DNA K-ras mutations in patients with gastrointestinal malignancies.
    Mulcahy HE; Lyautey J; Lederrey C; Chen XQ; Lefort F; Vasioukhin V; Anker P; Alstead EM; Farthing MJ; Stroun M
    Ann N Y Acad Sci; 2000 Apr; 906():25-8. PubMed ID: 10818591
    [No Abstract]   [Full Text] [Related]  

  • 17. K-ras mutations appear in the premalignant phase of both microsatellite stable and unstable endometrial carcinogenesis.
    Mutter GL; Wada H; Faquin WC; Enomoto T
    Mol Pathol; 1999 Oct; 52(5):257-62. PubMed ID: 10748874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characteristics of plasma DNA and its application for detection of K-ras gene mutation].
    Hayashi T; Sugahara K; Dateki N; Yamada Y; Sudou R; Kanematsu T; Kamihira S
    Rinsho Byori; 2000 Jun; 48(6):547-53. PubMed ID: 10897674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K-ras point mutations in endometrial carcinoma: effect on outcome is dependent on age of patient.
    Ito K; Watanabe K; Nasim S; Sasano H; Sato S; Yajima A; Silverberg SG; Garrett CT
    Gynecol Oncol; 1996 Nov; 63(2):238-46. PubMed ID: 8910634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of clonality and genetic alterations in endometrial pipelle biopsy and its surgical specimen counterpart.
    Esteller M; García A; Martínez-Palones JM; Xercavins J; Reventós J
    Lab Invest; 1997 Jan; 76(1):109-16. PubMed ID: 9010454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.